v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at beginning of period at Dec. 31, 2024 $ 310 $ 157,073 $ (137,619) $ (2,483) $ 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     992   992
Unrealized income (loss) on foreign exchange rate translation       (30) (30)
Stock-based compensation expense   44     44
Issuance of common stock as compensation (in shares) 1,050        
Shares exchanged for taxes on stock-based compensation (in shares) (325)        
Balance at end of period at Mar. 31, 2025 $ 310 157,117 (136,627) (2,513) 18,287
Balance at end of period (in shares) at Mar. 31, 2025 30,984,162        
Balance at beginning of period at Dec. 31, 2024 $ 310 157,073 (137,619) (2,483) 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         (1,357)
Balance at end of period at Jun. 30, 2025 $ 310 157,115 (138,976) (2,036) 16,413
Balance at end of period (in shares) at Jun. 30, 2025 31,047,801        
Balance at beginning of period at Mar. 31, 2025 $ 310 157,117 (136,627) (2,513) 18,287
Balance at beginning of period (in shares) at Mar. 31, 2025 30,984,162        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     (2,349)   (2,349)
Unrealized income (loss) on foreign exchange rate translation       477 477
Stock-based compensation expense   43     43
Issuance of common stock as compensation (in shares) 91,100        
Shares exchanged for taxes on stock-based compensation   (45)     (45)
Shares exchanged for taxes on stock-based compensation (in shares) (27,461)        
Balance at end of period at Jun. 30, 2025 $ 310 157,115 (138,976) (2,036) 16,413
Balance at end of period (in shares) at Jun. 30, 2025 31,047,801        
Balance at beginning of period at Dec. 31, 2025 $ 311 157,154 (139,560) (2,097) $ 15,808
Balance at beginning of period (in shares) at Dec. 31, 2025 31,052,840       31,052,840
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     7,661   $ 7,661
Unrealized income (loss) on foreign exchange rate translation       (186) (186)
Stock-based compensation expense   47     47
Balance at end of period at Mar. 31, 2026 $ 311 157,201 (131,899) (2,283) 23,330
Balance at end of period (in shares) at Mar. 31, 2026 31,052,840        
Balance at beginning of period at Dec. 31, 2025 $ 311 157,154 (139,560) (2,097) $ 15,808
Balance at beginning of period (in shares) at Dec. 31, 2025 31,052,840       31,052,840
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         $ 4,221
Balance at end of period at Jun. 30, 2026 $ 311 157,263 (135,339) (2,198) $ 20,037
Balance at end of period (in shares) at Jun. 30, 2026 31,055,618       31,055,618
Balance at beginning of period at Mar. 31, 2026 $ 311 157,201 (131,899) (2,283) $ 23,330
Balance at beginning of period (in shares) at Mar. 31, 2026 31,052,840        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     (3,440)   (3,440)
Unrealized income (loss) on foreign exchange rate translation       85 85
Stock-based compensation expense   46     46
Issuance of common stock as compensation   23     23
Issuance of common stock as compensation (in shares) 4,000        
Shares exchanged for taxes on stock-based compensation   (7)     (7)
Shares exchanged for taxes on stock-based compensation (in shares) (1,222)        
Balance at end of period at Jun. 30, 2026 $ 311 $ 157,263 $ (135,339) $ (2,198) $ 20,037
Balance at end of period (in shares) at Jun. 30, 2026 31,055,618       31,055,618